Dyspnoea in COPD: Can inspiratory muscle training help?  by Hill, Kylie et al.
Introduction
Chronic obstructive pulmonary disease (COPD) is the third
most burdensome disease and fourth leading cause of death in
Australia (Mathers et al 1999). It is associated with escalating
hospital admission rates (Hurd 2000) and economic burden
(Burdon and Edwards 2002) with its incidence rising rapidly
in women (Burdon and Edwards 2002). Dyspnoea limiting
physical activity is a common complaint in COPD patients
with moderate to severe airflow obstruction (NHLBI/WHO
Workshop Report 2001), and usually arises during the sixth or
seventh decade of life (Celli et al 1995). The onset of
dyspnoea is often insidious and may be attributed incorrectly
to the effects of ageing (McKenzie et al 2003). Avoidance of
activity as a strategy to limit the experience of dyspnoea leads
to a sedentary lifestyle. Accompanying this lifestyle is
locomotor muscle deconditioning (Maltais et al 2000) which
compounds the effects of pulmonary dysfunction on
dyspnoea (Sassi-Dambron et al 1995). Progression of COPD
results in dyspnoea advancing from being present only during
exertion to ultimately becoming an incapacitating feature
during activities of daily living (McKenzie et al 2003) with
reduced health-related quality of life (Shoup et al 1997).
Optimising function through a reduction in dyspnoea has
been identified as a key goal in the Australia and New
Zealand guidelines for the management of COPD (McKenzie
et al 2003). Following appropriate pharmacological therapy,
pulmonary rehabilitation is the only treatment shown
convincingly to reduce dyspnoea (McKenzie et al 2003). This
reduction is thought to be mediated via decreased levels of
ventilation during submaximal exercise resulting from
training-induced improvements in aerobic capacity of the
skeletal muscles lowering blood lactate concentration and
increased mechanical efficiency of these muscles (Casaburi et
al 1991, O’Donnell et al 1995). It is notable that such whole
body exercise training does not improve respiratory muscle
strength or endurance (Belman and Kendregan 1982, Wanke
et al 1994, Weiner et al 1992). Because inspiratory muscle
dysfunction contributes to the origin of dyspnoea in COPD
(Rochester 1991), it is possible that the addition of specific
inspiratory muscle training to an existing program of whole
body exercise may yield further reductions in dyspnoea.
The purpose of this review is three-fold: first, to describe the
physiological origins of dyspnoea in COPD, with particular
attention on inspiratory muscle dysfunction in its genesis;
second, to review the results of randomised controlled trials
investigating the effects of inspiratory muscle training on
dyspnoea in COPD; and third, to analyse the possible
mechanisms by which inspiratory muscle training may lead to
a reduction in dyspnoea. In contrast, previous reviews of
inspiratory muscle training in COPD have focussed on
respiratory muscle function and assessment, inspiratory
muscle training regimens, and the methodological limitations
of inspiratory muscle training studies (Grassino 1989, Reid
and Samrai 1995, Reid and Sharma 2000).
Defining and describing dyspnoea
Dyspnoea has been defined as ‘a subjective experience of
breathing discomfort that consists of qualitatively distinct
sensations that vary in intensity. The experience derives from
interactions among multiple physiological, psychological,
social, and environmental factors, and may induce secondary
physiological and behavioural responses’ (American
Thoracic Society 1999). Put simply, dyspnoea is an
unpleasant sensation of breathing arising as a consequence of
complex and varied interactions. The sensation is multi-
dimensional and differs in intensity (Simon et al 1990).
Cerebral processes appear to alter the intensity of dyspnoea
with anxiety, anger, depression, and cognitive disturbance
each heightening the perception (Dales et al 1989).
Dyspnoea is a feature of many disease processes. It appears
that the phraseology selected by individuals to describe their
experience of dyspnoea reflects, in part, the underlying
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pathophysiological origin. COPD subjects tend to choose
terminology pertaining to effort associated with increased
mechanical loads (Elliot et al 1991).
Measuring dyspnoea
Dyspnoea during exercise is usually measured using interval
scales such as the Borg-Category Ratio scale (Borg 1982).
This requires the patient to ascribe a value representative of
the magnitude of dyspnoea, ranging from 0 to 10 anchored
with simple verbal descriptions of intensity such as ‘very,
very slight’ and ‘severe’ (Borg 1982). Following instruction,
measurements of dyspnoea using this scale are simple to
collect, reliable over short periods of time, sensitive to
change, and correlate with minute ventilation and oxygen
consumption during exercise in subjects with COPD (Mador
et al 1995, Mahler 1992). A difference of one point has been
suggested to be clinically significant (Solway et al 2002).
Dyspnoea during activities of daily living is usually measured
with either the Chronic Respiratory Disease Questionnaire
(CRDQ) (Guyatt et al 1987) or the Baseline Dyspnoea
Index/Transitional Dyspnoea Index (BDI/TDI) (Mahler et al
1984). The CRDQ is a disease-specific quality of life
questionnaire evaluating four domains: dyspnoea, mastery,
emotional function, and fatigue (Guyatt et al 1987). It is used
to measure change in dyspnoea in response to an intervention
or over time, with higher numbers representing less dyspnoea
(Guyatt et al 1987). The CRDQ has been shown to be
reproducible, valid and responsive in subjects with chronic
airflow limitation (Guyatt et al 1987). A minimal clinically
important difference is defined as 0.5 points per item
(Jaeschke et al 1989).
The BDI/TDI quantifies dyspnoea by summation of values
ascribed for three categories: functional impairment,
magnitude of task, and magnitude of effort, resulting in a
focal score (Mahler et al 1984). A higher focal score in the
BDI is representative of less impairment at baseline, whereas
a higher score for the TDI indicates a reduction in dyspnoea
compared with baseline values (Mahler et al 1984). Both the
BDI and TDI are reliable and valid in subjects with chronic
lung disease (Mahler et al 1984, Witek and Mahler 2003). The
TDI is sensitive to change in COPD subjects with a difference
of one point described as clinically important (Witek and
Mahler 2003).
The origin of dyspnoea in COPD
Complex integration of multiple afferent and efferent signals
has been implicated in the perception of dyspnoea (American
Thoracic Society 1999). A widely accepted view is that
dyspnoea as a limiting symptom reflects disequilibrium
between ventilatory capacity and ventilatory demand (Polkey
2002). Factors that increase demand on the ventilatory system
are likely to result in dyspnoea when the ventilatory capacity
is inadequate to meet heightened ventilatory needs.
Neuromechanical disassociation is a popular theory
explaining the contribution of respiratory muscle dysfunction
in the genesis of dyspnoea (American Thoracic Society
1999). This theory postulates that dyspnoea arises from
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Figure 1. Factors contributing to dyspnoea in COPD.
          
disequilibrium between respiratory motor command (central
inspiratory motor activity) and the corresponding afferent
feedback from proprioceptive and other sensory receptors.
Thus, when the afferent feedback relating to changes in
intrathoracic pressure, respiratory muscle length, chest wall
or lung movement are interpreted as insufficient for the
corresponding motor command, dyspnoea arises. In COPD,
measurements reflecting inspiratory muscle activity such as
the percentage of maximum pressure required to generate
airflow or the level of exercise ventilation have been shown
to relate to the intensity of dyspnoea, adding credence to this
theory (Leblanc et al 1986, O’Donnell and Webb 1993).
Factors implicated in the origin of dyspnoea
Factors contributing to the origin of dyspnoea in COPD are
summarised in Figure 1 and discussed in greater detail in the
following sections.
Inspiratory muscle dysfunction
In COPD, dyspnoea is greater in subjects requiring a higher
proportion of their maximum inspiratory pressure to generate
inspiratory airflow (Gorini et al 1996). An increase in this
proportion gives rise to a sensation of inspiratory effort,
postulated to result from the perception of the heightened
motor command through corollary discharge within the
central nervous system (El-Manshawi et al 1986, Gandevia et
al 1981). In COPD subjects, inspiratory muscle weakness and
inefficiency will increase the proportion of maximum
inspiratory pressure required to generate inspiratory flow
thereby yielding a greater sense of inspiratory effort
(Gandevia et al 1981). This mechanism is likely to contribute
to the origin of dyspnoea as sensations of inspiratory effort
and breathlessness appear to be closely related (Killian et al
1984).
Mechanical loads on the inspiratory system
Elastic loads Elastic loads refer to those muscle loads
imposed by the stiffness of the lungs and chest wall
(O’Donnell 1994). These loads are increased when breathing
from high lung volumes, as the associated decrease in lung
and chest wall compliance requires the inspiratory muscles to
generate greater negative pleural pressures during inspiration
(O’Donnell and Webb 1993, Rochester 1991).
Threshold loads A consequence of pulmonary hyperinflation
(see below) is a positive intra-alveolar pressure at end
expiration, as expiration is incomplete and inward recoil of
the lungs and chest wall persists (Marchand and Decramer
2000, O’Donnell 2002). This has been termed intrinsic
positive end expiratory pressure (Marchand and Decramer
2000) and represents a threshold load which must be
overcome during the succeeding inspiratory effort before
flow can commence (O’Donnell 2002).
Resistive loads Narrowing of peripheral airways imposes a
resistive load on both the inspiratory and expiratory muscles
(Rochester 1991). In COPD, this narrowing occurs as a result
of the loss of elastic support of airways (in the case of
emphysema) and inflammation. Most commonly this
inflammatory reaction is induced by inhalation of noxious
particles or gases (such as those present in cigarette smoke).
The inflammatory reaction causes narrowing of the lumen and
fibrosis of the airway wall, culminating in fixed obstruction to
airflow (NHLBI/WHO Workshop Report 2001).
Conditions reducing inspiratory muscle strength and
efficiency
Pulmonary hyperinflation Peripheral airway narrowing and
loss of elastic recoil leads to gas trapping during expiration,
resulting in a progressive increase in functional residual
capacity, termed pulmonary hyperinflation (NHLBI/WHO
Workshop Report 2001, Rochester 1991). These changes
limit the ability of the ventilatory system to accommodate the
rise in alveolar ventilation during exercise by increasing tidal
volumes (Marin et al 2001) resulting in abnormally high
increases in respiratory rate (Moss and Make 1993). The
consequent reduction in expiratory time in the presence of
expiratory airflow limitation leads to an incomplete
expiration further tending to increase end expiratory lung
volume and reduce inspiratory reserve capacity (Moss and
Make 1993, O’Donnell and Webb 1993). This dynamic
pulmonary hyperinflation is associated with dyspnoea during
both walking (Marin et al 2001) and cycle ergometry exercise
(O’Donnell and Webb 1993).
Besides imposing elastic and threshold loads on the
inspiratory muscles, pulmonary hyperinflation results in a
suboptimal length-tension relationship of the diaphragm
(Rochester et al 1979). The flattening and shortened resting
length of the diaphragm decreases its pressure-generating
capacity through mechanical disadvantage (Lahrmann et al
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Figure 2. The relationship between force of contraction,
duration of contraction, and fatigue of the diaphragm is
shown. Duration of the contraction is expressed as the ratio
of inspiratory time (Ti) to the total respiratory cycle (Ttot) on
the ordinate. Force of the contraction is expressed as the
ratio of transdiaphragmatic pressure required per breath
(Pdi) to the maximum transdiaphragmatic pressure (Pdimax).
The isopleths have numeric values of 0.1 and 0.2. The
closed circle represents a normal subject breathing quietly,
and the open circle represents the effects if inspiratory
resistive loading (IRL). The closed triangle depicts a patient
with chronic obstructive pulmonary disease breathing quietly,
whereas the open triangle depicts such a patient breathing
slowly and deeply, or alternatively, what might occur during
acute respiratory failure (ARF). Reproduced with kind
permission of Elsevier from Rochester D et al (1983):
Respiratory Muscle Failure. Medical Clinics of North
America. The American Physiological Society granted
permission for the continued use Rochester made of data
from Bellemare F and Grassino A (1982): Effect of pressure
and timing of contraction on human diaphragm fatigue.
Journal of Applied Physiology 53: 1190–1195.
                      
1999, Rochester and Braun 1985). Therefore relief of
dyspnoea following a reduction in pulmonary hyperinflation
with treatment is likely to be the consequence both of
decreased threshold and elastic loading and of improved
diaphragmatic mechanics (Lahrmann et al 1999).
Respiratory muscle fatigue Inspiratory muscle fatigue
reduces inspiratory muscle strength (Supinski et al 1987) and
is therefore likely to increase the sense of respiratory effort.
The pattern of breathing adopted, specifically the
components of inspiratory pressure and inspiratory time,
influence the development of respiratory muscle fatigue
(Bellemare and Grassino 1982) and the perceived magnitude
of a respiratory load (Killian et al 1982). The mean
inspiratory pressure (expressed as a proportion of maximum)
multiplied by the duty cycle (inspiratory time expressed as a
proportion of total respiratory cycle time) is defined as the
tension-time index which is a primary determinant of
diaphragmatic fatigue (Bellemare and Grassino 1982). If the
tension-time index is maintained above 0.15 for a prolonged
period of time, fatigue may develop (Bellemare and Grassino
1982). This relationship between pattern of breathing and the
development of inspiratory muscle fatigue is shown in Figure
2 (Rochester and Arora 1983).
Respiratory muscle oxygen consumption  In COPD the
percentage of total oxygen consumption required by the
respiratory muscles is estimated to be 8 to 12 times higher
than that required by healthy individuals during exercise and
quiet breathing respectively (Rochester 1991). The higher
respiratory muscle oxygen consumption reflects the
increased load on, and reduced efficiency of, the respiratory
muscles (Cherniack 1959, Field et al 1982) and may
contribute to dyspnoea and exercise limitation (Aliverti and
Macklem 2001). In healthy subjects, imposition of an
external mechanical load on the respiratory muscles
decreases the oxygen consumption of locomotor muscles
during maximal exercise, whereas unloading the respiratory
muscles results in an increase in oxygen consumption of the
locomotor muscles (Harms et al 1997). While no comparable
data exist in patients with COPD, these findings support the
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view of a competition between the respiratory muscles and
the skeletal muscles for oxygen during exercise so that the
limiting symptom of either dyspnoea or leg fatigue reflects
the muscle group left with an inadequate oxygen supply
(Aliverti and Macklem 2001). Therefore, the development of
dyspnoea in COPD as the limiting symptom during activity
has been proposed to reflect an unfavourable balance
between heightened demand for and inadequate supply of
oxygen to the respiratory muscles (Aliverti and Macklem
2001). Reduced oxygen supply to the diaphragm increases
lactate concentration and the rate of inspiratory muscle
fatigue (Jardim et al 1981), thereby potentially decreasing the
maximum force-generating capacity of the inspiratory
muscles (see respiratory muscle fatigue), giving rise to
dyspnoea through heightened neuro-mechanical
disassociation.
Weight loss Compared with those of normal weight,
underweight COPD patients have weaker inspiratory muscles
and report higher levels of dyspnoea (Sahebjami and
Sathianpitayakul 2000). The reduced diaphragmatic mass
(Thurlbeck 1978) and disproportionate atrophy of type II
muscle fibres (Marchand and Decramer 2000) reported in
underweight COPD subjects are both likely to contribute to
the impairment of inspiratory muscle strength and
consequent heightened sensation of dyspnoea.
Morphological and biochemical factors A shift in the
proportion of muscle fibres from type II (fast twitch,
glycolytic) to type I (slow twitch, oxidative) has been
demonstrated in the diaphragm of patients with severe COPD
(Levine et al 1997). These changes, postulated to develop in
response to chronic loading (Levine et al 1997), may improve
the ability of the diaphragm to withstand fatigue, potentially
at the expense of its maximal force-generating capacity
(Gosker et al 2000, Marchand and Decramer 2000). Other
factors which may reduce inspiratory muscle strength include
corticosteroid-induced myopathy, chronic gas exchange
abnormalities, chronic inflammation and hormone or
electrolyte disturbances (Casaburi 2000, Maltais et al 2000).
Figure 3a. Pressure-flow characteristics of a resistive
inspiratory muscle training device. Reproduced with kind
permission from Belman MJ, Thomas S and Lewis MI
(1986): Resistive breathing training in patients with chronic
obstructive pulmonary disease. Chest 90: 662–669.
Figure 3b. Pressure-flow characteristics of a threshold
inspiratory muscle training device. Reproduced with kind
permission from Eastwood PR and Hillman DR (1995): A
threshold loading device for testing of inspiratory muscle
performance. European Respiratory Journal 8: 463–466.
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Other causes of dyspnoea in COPD
Locomotor muscle dysfunction The quadriceps muscles of
patients with COPD have been shown to have abnormal
morphology and biochemistry including a reduction in type I
fibres, an increase in the percentage of type IIb fibres
(Whittom et al 1998), and a reduction in the concentration of
oxidative enzymes (Maltais et al 2000). Impairment in
skeletal muscle oxidative capacity has been postulated to
explain the early dependence on anaerobic energy systems
seen during exercise in COPD, characterised by an unusually
early and steep rise in arterial lactate concentrations (Maltais
et al 1996). Lactic acidosis stimulates chemoreceptor drive
and ventilation, increasing inspiratory motor command,
thereby promoting dyspnoea (Casaburi et al 1991, O’Donnell
and Webb 1993).
Gas exchange abnormalities Decreased single-breath
diffusing capacity for carbon monoxide and exercise-induced
desaturation characterise COPD patients with severe
dyspnoea (O’Donnell and Webb 1992). Abnormal gas
exchange arising as a consequence of ventilation/perfusion
mismatch can contribute to the genesis of dyspnoea
(American Thoracic Society 1999, NHLBI/WHO Workshop
Report 2001). Hypoxia may result in increased reliance on
anaerobic energy systems with subsequent lactate production
stimulating ventilation, contributing to dyspnoea. Supporting
this hypothesis is the finding that administration of
supplementary oxygen to COPD subjects during exercise
reduces lactate concentration and ventilation (O’Donnell et al
1997). Such a reduction in ventilation would also reduce
pulmonary hyperinflation and, in turn, dyspnoea resulting
from this mechanism (Marin et al 2001, O’Donnell and Webb
1993).
In patients with lung disease, acute hypercapnia elicits a
chemoreceptor-driven increase in inspiratory motor
command, which gives rise to dyspnoea (American Thoracic
Society 1999, Manning and Schwartzstein 1995). Chronic
carbon dioxide retention has also been associated with greater
dyspnoea during activities of daily living (Gorini et al 1996).
However this relationship is unlikely to be due to carbon
dioxide-induced increases in chemoreceptor activity, as
gradual renal compensatory activity acts to buffer pH changes
and minimise medullary chemoreceptor stimulation
(American Thoracic Society 1999). A more likely cause of
this relationship is the gradual deterioration in lung
mechanical properties and inspiratory muscle function
referred to earlier, which results in a relatively high force
required for each breath and the subsequent development of a
rapid, shallow breathing pattern (Begin and Grassino 1991,
Gorini et al 1996). Such a breathing pattern minimises
inspiratory muscle fatigue, inspiratory muscle effort and
dyspnoea, but at the expense of alveolar ventilation (Begin
and Grassino 1991, Gorini et al 1996). Thus greater dyspnoea
reported by COPD patients with chronic carbon dioxide
retention is more likely to arise from neuromechanical
disassociation due to an imbalance between load and the
capacity of the inspiratory muscles to cope (Gorini et al
1996).
Inspiratory muscle training
Despite the reductions in dyspnoea demonstrated following
whole body exercise training in COPD (Lacasse et al 2002)
measures of inspiratory muscle strength and endurance
remain unchanged (Wanke et al 1994, Weiner et al 1992).
This is probably because the increased ventilation
accompanying whole body exercise is of insufficient intensity
to induce a training effect in the inspiratory muscles (Kraemer
et al 1996). However, it is possible to improve inspiratory
muscle function using techniques which selectively load the
inspiratory muscles at a level greater than that experienced
during whole body exercise, prompting investigation of the
role of inspiratory muscle training. While several studies have
been undertaken, it remains unresolved whether
improvements in inspiratory muscle function can reduce
dyspnoea during the activities of the daily living in these
patients.
Loading the respiratory muscles
Low pressure–high flow loads  Normocapnic hyperpnoea
was first described as a method for training the respiratory
muscles of healthy subjects in 1976 (Leith and Bradley 1976)
and COPD subjects in 1980 (Belman and Mittman 1980). It
involves training the respiratory muscles by voluntarily
ventilating at high levels for a prolonged period (usually 15
minutes) (Belman and Mittman 1980). The load imposed
requires the generation of low pressures but high flows (Reid
and Sharma 2000), and is therefore analogous to the high
ventilatory demands placed on the respiratory muscles during
exercise (Belman 1993). Widespread use of the technique has
not eventuated because of the need to use complex breathing
circuits to ensure stable levels of carbon dioxide (Belman and
Mittman 1980) and the difficulty in accurately determining
the inspiratory muscle load due to the inter- and intra-
individual variability in airflow obstruction (Clanton et al
2002). This modality is therefore usually reserved for
laboratory-based trials with few studies reporting its use in
the clinical setting (Ries and Moser 1986, Scherer et al 2000).
High pressure–low flow loads  The inspiratory muscle
training loads most commonly described in the literature are
high pressure–low flow in nature, imposed by external
mechanical loading devices. Such loads can be achieved by
either resistive or threshold devices.
Resistive loads Resistive inspiratory muscle training devices
provide a range of different sized apertures to impose varying
resistive loads (Harver et al 1989). The primary disadvantage
of this method is the interdependence of flow and inspiratory
pressure (Figure 3a) (Belman et al 1986). In practical terms
this means if inspiratory flow rates are not controlled, patients
can lower the training load imposed by the device by
manipulating their breathing pattern (Reid and Sharma 2000).
Training programs utilising resistive loading have usually
prescribed repeated submaximal inspiratory efforts, with
sessions between 15 and 30 minutes in duration, once to four
times a day, seven days a week and for between six and eight
weeks (Belman and Shadmehr 1988, Belman et al 1986,
Harver et al 1989, Pardy et al 1981, Patessio et al 1989, Sonne
and Davis 1982) at a training intensity ranging from
approximately 30–70% of maximum inspiratory pressure
(Dekhuijzen et al 1991, Harver et al 1989).
Threshold loads Threshold inspiratory muscle training
devices impose a threshold or critical opening pressure that
must be overcome prior to inspiratory flow commencing
(Flynn et al 1989). During the task, inspiratory muscles
initially perform an isometric contraction until the threshold
valve opens to allow inspiratory flow, after which the
contraction becomes isotonic in nature. In contrast to resistive
loading, threshold loading has the advantage of inspiratory
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pressure being largely independent of flow rate (Nickerson
and Keens 1982) such that manipulations in breathing pattern
to change inspiratory flow rates will not alter the inspiratory
load imposed by the device (Figure 3b) (Eastwood and
Hillman 1995). For this reason threshold loading devices
have become a popular choice with which to train the
inspiratory muscles. Generally, training programs using
threshold devices have applied similar strategies to those
described using resistive devices (Berry et al 1996, Larsen et
al 1988, Villafranca et al 1998).
Specificity of training related improvements
As with whole body exercise performance, improvements in
measures of inspiratory muscle function follow the principle
of task specificity, reflecting the prescribed method of
training (Romer and McConnell 2003, Tzelepis et al 1994).
High pressure–no flow contractions yield strength gains,
whereas high flow–low pressure contractions improve
maximum inspiratory flow rates (Romer and McConnell
2003, Tzelepis et al 1994) and measures of inspiratory muscle
endurance (Scherer et al 2000). Training protocols employing
a combination of pressure and flow loads yield gains in
strength, maximal inspiratory flow rates (Romer and
McConnell 2003, Tzelepis et al 1994), and inspiratory muscle
endurance (Belman and Shadmehr 1988). Transfer of
improvement from pressure-based training to flow-based
measures of endurance appears possible when the training
load is maximised (Belman and Shadmehr 1988). While most
studies employing continuous (without rest) training
protocols prescribe loads between 30% and 50% of the
baseline maximum inspiratory pressure (Harver et al 1989,
Lisboa et al 1997, Ramirez-Sarmiento et al 2002, Riera et al
2001, Villafranca et al 1998), some report using training loads
as high as 70% or even 80% of baseline inspiratory muscle
pressure (Berry et al 1996, Dekhuijzen et al 1991). However,
a recent study using an interval-based training program
allowed considerably higher training loads to be achieved (up
to 95% of the baseline maximum inspiratory pressure) thus
potentially maximising gains in inspiratory muscle function
(Sturdy et al 2003).
Effects of inspiratory muscle training on inspiratory muscle
strength and endurance
Several recent randomised controlled trials of inspiratory
muscle training employing protocols of repeated submaximal
efforts imposed by external loading devices, report gains in
inspiratory muscle strength or endurance in the experimental
group compared with baseline measurements (Lisboa et al
1997, Ramirez-Sarmiento et al 2002, Villafranca et al 1998,
Weiner et al 2000) or gains greater than those reported in the
control group (Larsen et al 1999, Riera et al 2001).
Prescribing training loads as low as 22% of the previously
determined maximum inspiratory pressure appears capable of
improving inspiratory muscle endurance, but not strength
(Preusser et al 1994). It appears that training loads of at least
30% of the maximum inspiratory pressure are required before
improvements in strength are achieved (Larsen et al 1988).
This observation is in keeping with the conclusions of a
recent meta-analysis of inspiratory muscle training that
described improvements in both inspiratory muscle strength
and endurance when the analysis was restricted to studies
employing loads of at least 30% of maximum inspiratory
pressure (Lotters et al 2002).
Studies comparing differing intensities of inspiratory muscle
training in COPD demonstrate more pronounced gains in
strength and endurance in those subjects training at the higher
intensity, suggesting a dose-dependent response in training
adaptations (Belman and Shadmehr 1988, Larsen et al 1988,
Lisboa et al 1997, Preusser et al 1994, Villafranca et al 1998).
In addition to the improvements in inspiratory muscle
strength and endurance, structural changes in muscle
morphology indicative of adaptation have recently been
reported following inspiratory muscle training in COPD
(Ramirez-Sarmiento et al 2002). These changes included an
increase in the proportion of type I fibres and an increase in
the size of the type II fibres in the external intercostal muscle
(Ramirez-Sarmiento et al 2002).
Effects of inspiratory muscle training on dyspnoea and
exercise capacity
To date, only six randomised controlled trials have reported
the effects of inspiratory muscle training, when performed in
isolation, on dyspnoea measured with the CRDQ, the
BDI/TDI, or Borg scores at the end of exercise testing (Table
1a). Of these, four trials utilised training loads that appeared
likely to yield gains in inspiratory muscle strength above
baseline measures and also reported significant reductions in
dyspnoea during activities of daily living (Harver et al 1989,
Lisboa et al 1997, Riera et al 2001, Scherer et al 2000). These
findings are summarised in Figure 4, which plots the
relationship between the improvement in inspiratory muscle
strength and the reduction in dyspnoea for those studies using
the TDI. The association between these variables is strong (r
= 0.94) although not statistically significant (p = 0.06),
possibly because of the limited number of studies available
for this analysis. The trend towards a significant association
suggests that inspiratory muscle training protocols which
induce greater improvements in inspiratory muscle strength
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Figure 4. Relationship between change in PImax and TDI in
the experimental groups following IMT for studies
summarised in Table 1a, using TDI as the outcome measure
for dyspnoea. PImax and TDI are expressed as the change
in experimental groups above the change in control groups.
= Scherer et al (2000)
= Lisboa et al (1997)
= Harver et al (1989)
= Riera et al (2001)
                
may also result in larger reductions in dyspnoea. Whether the
magnitude of the reduction in dyspnoea during activities of
daily living is actually dependent upon the magnitude of gain
in inspiratory muscle strength will require studies designed to
specifically address this question. Notably, three of these
studies demonstrated post-inspiratory muscle training
improvements in walking tests of functional exercise capacity
with either similar or reduced end-exercise Borg scores,
suggesting a faster pace was achieved with equal or less
dyspnoea (Hsiao et al 2003, Lisboa et al 1997, Riera et al
2001).
A reduction in dyspnoea during activities of daily living is
seen in COPD patients following whole body exercise
training (Lacasse et al 2002) and also following inspiratory
muscle training, prescribed at an adequate training intensity.
Hence, an important question is whether combining
inspiratory muscle training with whole body exercise training
confers additional reductions in dyspnoea beyond those seen
following whole body exercise training alone. To date, only
three randomised controlled trials measuring dyspnoea with
the Borg or CRDQ have addressed this question (Table 1b)
(Berry et al 1996, Larsen et al 1999, Wanke et al 1994).
Two of the three studies demonstrated improvements in
inspiratory muscle strength above gains reported in the
control groups following the addition of inspiratory muscle
training to a standard program of whole body exercise
(Larsen et al 1999, Wanke et al 1994). In the study by Wanke
et al (1994), greater gains in whole body exercise capacity
were described in the subjects receiving both inspiratory
muscle training and cycle ergometry training compared with
the improvements described in the subjects receiving cycle
ergometry training in isolation. The addition of inspiratory
muscle training yielded a 38% increase in inspiratory muscle
strength from baseline measurements. The Borg scores at
end-exercise were similar between the groups, suggesting that
the group receiving inspiratory muscle training combined
with cycle ergometry training were able to achieve higher
work rates before dyspnoea limited performance (Wanke et al
1994). In the study by Larsen et al (1999), the improvement
in inspiratory muscle strength following the addition of
inspiratory muscle training to a program of cycle ergometry
training was only 20% above baseline measures and did not
translate into further gains in whole body exercise capacity or
reductions in dyspnoea relative to the gains made by those
subjects receiving cycle ergometry training alone.
As with dyspnoea, perhaps improvements in measures of
whole body exercise capacity following inspiratory muscle
training are likely to be related to the magnitude of the gains
in inspiratory muscle strength. From the results of all studies
presented in Table 1a and 1b, it appears that a minimum of
30% improvement in inspiratory muscle strength from
baseline measures is necessary before improvements in
exercise capacity are conferred (Hsiao et al 2003, Lisboa et al
1997, Riera et al 2001, Scherer et al 2000, Wanke et al 1994).
Mechanisms by which inspiratory muscle training may
reduce dyspnoea
As dyspnoea appears to arise, at least in part, from the
neuromechanical disassociation of inspiratory motor
command and afferent feedback from pulmonary and chest
wall mechanoreceptors (American Thoracic Society 1999),
therapies capable of reducing this disequibilirium may
ameliorate dyspnoea. Training-induced gains in inspiratory
muscle strength result from both hypertrophy of muscle fibres
(Ramirez-Sarmiento et al 2002) and adaptation of neural
pathways (Huang et al 2002). In healthy individuals, strength
gains following inspiratory muscle training correlate with a
reduction in inspiratory motor command, possibly reflecting
a decrease in the percentage of motor units required for a
ventilatory task (Huang et al 2002). If inspiratory muscle
training in patients with COPD results in a similar lower
utilisation of motor units for specific ventilatory tasks, this
should decrease the perception of inspiratory effort and
dyspnoea.
In COPD patients, inspiratory muscle training using threshold
devices has been demonstrated to increase the velocity of
shortening and reduce inspiratory time during loaded
breathing tasks (Flynn et al 1989, Villafranca et al 1998).
Providing the total respiratory cycle time remains unchanged,
adopting a reduced inspiratory time during exercise would
increase expiratory time for any given level of ventilation
(Belman and Shadmehr 1988). Such an increase in expiratory
time could reduce dyspnoea by decreasing dynamic
pulmonary hyperinflation (Marin et al 2001, O’Donnell and
Webb 1993) as well as increasing relaxation time and oxygen
delivery to the diaphragm (Buchler et al 1985), thereby
reducing inspiratory muscle fatigue (Bellemare and Grassino
1982). However, to date is remains unclear whether such
changes in breathing pattern occur during exercise following
inspiratory muscle training.
As is the case with peripheral muscles following whole body
exercise training (Maltais et al 1996), it is possible that
inspiratory muscle training induces changes in muscle
metabolism which reduce dyspnoea. Improved efficiency of
the respiratory pump muscles with a decrease in inspiratory
muscle oxygen requirement has been postulated to account
for the lower levels of ventilation and coexistent reduction in
oxygen consumption during exercise following inspiratory
muscle training (Lisboa et al 1997). In severe COPD it is
possible respiratory muscle work contributes to the high
blood lactate levels during exercise (Engelen et al 1995).
Changes reflecting improved oxidative capacity of the
respiratory muscles reported following inspiratory muscle
training in COPD (Ramirez-Sarmiento et al 2002) may serve
to lower lactate production (Boutellier and Piwko 1992) or
facilitate increased lactate metabolism (Spengler et al 1999)
thereby contributing to the reduction in exercise ventilation
(Lisboa et al 1997).
Why is inspiratory muscle training not part of the
standard management?
Despite the theoretical benefits, the role of inspiratory muscle
training in COPD remains unclear and it is currently not
included as a standard component of a pulmonary
rehabilitation program in the evidence-based guidelines
(American Thoracic Society 1999, Morgan et al 2001, Ries et
al 1997). The inconclusive evidence for inspiratory muscle
training offered by randomised controlled trials may be due,
at least in part, to methodological inadequacies including
insufficient training intensities, insensitive outcome measures
and inadequate statistical power. The recent meta-analysis of
inspiratory muscle training studies reported improvement in
inspiratory muscle function and a reduction in dyspnoea
following inspiratory muscle training (Lotters et al 2002).
This finding pertains to groups of COPD patients and it is
important for clinicians to consider that the response of
individuals to inspiratory muscle training may be more
variable. As inspiratory muscle weakness is not the only
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Table 1b. Randomised controlled trials investigating the cumulative effects of inspiratory muscle training with whole body exercise on dyspnoea in COPD
Subjects and study design Training Protocol Outcomes
Author N Mean FEV1 Compliance Control Training Intensity Training IMT Inspiratory Inspiratory Dyspnoea Changes in Changes in
% pred monitoring group modality duration frequency muscle strength muscle assessment dyspnoea in dyspnoea in
for IMT training % change endurance in method trained group control group
from baseline trained group
Wanke IMT + EX = 21 IMT + EX = 44 Supervised sessions EX alone Threshold 12 max sniffs, 8/52 4/7 10 min IMT + EX = 38** Improvement* Borg end Same end exercise
et al EX alone = 21 EX alone = 48 progressed from 10 sessions EX alone = 3.5 exercise Borg at higher 
1994 mins at 60-70% once daily maximum workrates 
baseline Pdi at FRC and ventilation**
Berry IMT + EX = 8 IMT + EX = 47 Home training 4/7, SIMT + EX or Threshold Up to 80% baseline 12/52 7/7 15 min No difference at Not assessed Borg during No difference at post
et al SIMT + EX = 9 SIMT + EX = 48 diary, supervised 3/7 SIMT + stretches PImax at RV sessions post training exercise training assessment
1996 SIMT + br ex + SIMT + br ex + +br EX 2 x daily, assessment between groups
stretches= 8 stretches = 45 between groups 
Larsen IMT + EX = 14 IMT + EX = 46 Home training, EX alone, IMT Threshold Up to 60% of 4/12 5/7 30 min IMT alone = 10†, Improvement in Borg during No further  improvement 
et al EX alone = 14 EX alone = 46 MD, diaries, visits alone or current PImax at RV sessions EX alone = 3.6 groups receiving exercise, as a result of IMT over
1999 IMT alone = 13 IMT alone = 55 by nurse education once daily IMT + EX = 20†, IMT† CRDQd those gains seen 
control = 12 control = 55 interval training education = 0 following EX
Table 1a. Randomised controlled trials investigating the effect of inspiratory muscle training in isolation on dyspnoea in COPD
Subjects and study design Training Protocol Outcomes
Author N Mean FEV1 Compliance Control Training Intensity Training IMT Inspiratory Inspiratory Dyspnoea Changes in Changes in
% pred monitoring group modality duration frequency muscle strength muscle assessment dyspnoea in dyspnoea in
for IMT training % change endurance in method trained group control group
from baseline trained group
Harver Trained = 10 Trained = 43 Home training: Sham trainer Resistive flow Up to 32%  of 8/52 7/7 15 min Trained = 32* Not assessed BDI/TDI TDI = 3.5** TDI = 0.3
et al Control = 9 Control = 33 diaries, phone feedback current PImax at sessions Control = 12
1989 calls, lab visits 4/52 FRC 2 x daily
Guyatt Trained = 43 Trained and Home training: Sham trainer, Resistive, Up to the maximum 6/12 7/7 10 min Trained = 0.2 No difference CRDQd, Borg No difference No difference
et al Control = 39 control < 70 visits from nurse breathing no feedback tolerable for 10 mins sessions Control = 1.6 between groups end exercise between groups between groups
1992 exercises 5 x daily Borg not reported Borg not reported
Lisboa Trained = 10 Trained = 40 Home training: 10% PImax Threshold 30% of current 10/52 6/7 30 min Trained = 34* Not assessed BDI/TDI, Borg TDI = 3.8**, TDI = 1.7, no 
et al Control = 10 Control = 37 lab visits 1/7 at FRC PImax at FRC sessions once Control = 19 end exercise lower Borg at end change to Borg 
1997 daily 6MWD** at end 6MWD
Scherer Trained = 15 Trained = 50 Home training: Incentive Normocapnic 60% of initial 8/52 5/7 15 min Trained = 30 Improvement** BDI/TDI TDI = 4.7 TDI = 2.9
et al Control = 15 Control = 52 diary, lab visits 1/7 spirometry hyperpnoea MVV, progressed sessions Control = 17
2000 2 x daily
Riera Trained = 10 Trained = 38 Home training: Sham trainer, Resistive flow 30% of current 6/12 6/7 15 min Trained = 48** Improvement** BDI/TDI, TDI = 4.7**, CRDQd TDI = 0.2, CRDQd 
et al 2001 Control = 10 Control = 41 lab visits 6/52 relaxation feedback FRC sessions Control = - 4 CRDQd, Borg 1.6**, improved ISWT < 0.2, no change in 
exercises 2 x daily end exercise same end exercise ISWT or end 
Borg ** exercise Borg 
Hsiao Trained Trained Home training: No training Threshold or 50% of current 8/52 5/7 15 min Threshold Improvement** Borg end Improved 6 MWD No change in 6 MWD
et al (threshold) = 10 (threshold) = 50 diaries, phone resistive with  PImax at RV sessions trained = 39* exercise same end exercise or end exercise
2003 Trained Trained calls, lab visits flow feedback 2 x daily Resistive Borg Borg
(resistive) = 10 (resistive) = 50 2/52 trained = 43*
Control = 10 Control = 54 Control = 18*
Key for Tables 1a and 1b
N = number of subjects; FEV1 %pred = forced expiratory volume in 1 second expressed as a percentage of the predicted value;
IMT = inspiratory muscle training; SIMT = sham inspiratory muscle training; PImax = maximum inspiratory mouth pressure; FRC
= functional residual capacity; RV = residual volume; BDI = baseline dyspnoea index; TDI = transitional dyspnoea index; CRDQd
= dyspnoea domain of the Chronic Respiratory Disease Questionnaire; 6MWD = distance achieved in the six-minute walk test;
lab = laboratory; MD = monitoring device; MVV = maximum voluntary ventilation; min(s) = minute(s); ISWT = incremental shuttle
walk test; EX = whole body exercise; br ex = breathing exercises; Pdi = transdiaphragmatic pressure; * = significant difference
from baseline measures; ** = significant difference in post training measures between treatment and control groups; † =
significant difference in post training measures in those groups receiving inspiratory muscle training compared with those groups
that did not. Difference between groups receiving inspiratory muscle training is not significant.
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noea in COPD
Training IMT Inspiratory Inspiratory Dyspnoea Changes in Changes in
duration frequency muscle strength muscle assessment dyspnoea in dyspnoea in
% change endurance in method trained group control group
from baseline trained group
8/52 4/7 10 min IMT + EX = 38** Improvement* Borg end Same end exercise
sessions EX alone = 3.5 exercise Borg at higher 
once daily maximum workrates 
and ventilation**
12/52 7/7 15 min No difference at Not assessed Borg during No difference at post
sessions post training exercise training assessment
2 x daily, assessment between groups
between groups 
4/12 5/7 30 min IMT alone = 10†, Improvement in Borg during No further  improvement 
sessions EX alone = 3.6 groups receiving exercise, as a result of IMT over
once daily IMT + EX = 20†, IMT† CRDQd those gains seen 
interval training education = 0 following EX
Outcomes
Training IMT Inspiratory Inspiratory Dyspnoea Changes in Changes in
duration frequency muscle strength muscle assessment dyspnoea in dyspnoea in
% change endurance in method trained group control group
from baseline trained group
8/52 7/7 15 min Trained = 32* Not assessed BDI/TDI TDI = 3.5** TDI = 0.3
sessions Control = 12
2 x daily
6/12 7/7 10 min Trained = 0.2 No difference CRDQd, Borg No difference No difference
s sessions Control = 1.6 between groups end exercise between groups between groups
5 x daily Borg not reported Borg not reported
10/52 6/7 30 min Trained = 34* Not assessed BDI/TDI, Borg TDI = 3.8**, TDI = 1.7, no 
sessions once Control = 19 end exercise lower Borg at end change to Borg 
daily 6MWD** at end 6MWD
8/52 5/7 15 min Trained = 30 Improvement** BDI/TDI TDI = 4.7 TDI = 2.9
sessions Control = 17
2 x daily
6/12 6/7 15 min Trained = 48** Improvement** BDI/TDI, TDI = 4.7**, CRDQd TDI = 0.2, CRDQd 
sessions Control = - 4 CRDQd, Borg 1.6**, improved ISWT < 0.2, no change in 
2 x daily end exercise same end exercise ISWT or end 
Borg ** exercise Borg 
8/52 5/7 15 min Threshold Improvement** Borg end Improved 6 MWD No change in 6 MWD
sessions trained = 39* exercise same end exercise or end exercise
2 x daily Resistive Borg Borg
trained = 43*
Control = 18*
     
contributor to dyspnoea in COPD (see Figure 1), inspiratory
muscle training yielding improvements in inspiratory muscle
function may not benefit all COPD patients. Furthermore, the
meta-analysis did not report additional benefits in those
studies combining inspiratory muscle training with whole
body exercise training on dyspnoea and functional exercise
capacity. Subgroup analysis of these studies revealed greater
improvements in inspiratory muscle strength in those subjects
with weaker inspiratory muscles and therefore inspiratory
muscle training offered in conjunction with whole body
exercise training is more likely to benefit those subjects with
marked inspiratory muscle weakness (Lotters et al 2002).
In conclusion, inspiratory muscle weakness in COPD is
known to contribute to dyspnoea (Hamilton et al 1995) and
exercise limitation (Gosselink et al 1996). It appears that
specific loading of the inspiratory muscles with commercially
available hand-held devices, using training intensities of at
least 30% of the previously determined maximum inspiratory
pressure can improve inspiratory muscle strength and
endurance (Lotters et al 2002). Results of randomised
controlled trials investigating the role of inspiratory muscle
training in reducing dyspnoea in COPD are promising but not
conclusive and further research is warranted to identify
possible predictors of improvement. Closer attention to
training intensity, outcome measures and statistical power
will help optimise training regimens and provide better
guidance regarding the role of inspiratory muscle training in
pulmonary rehabilitation programs.
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